Back to Search
JUAN TRIAS, MD
MD
Hematology & Oncology Physician
NPI: 1669958484IndividualAccepts Medicare
Specialties, Licenses & Credentials
Hematology & Oncology PhysicianPrimary
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
311684(NY)
Education
OTHER
Class of 2015
Research & Publications (20)
Varespladib (A-002), a secretory phospholipase A2 inhibitor, reduces atherosclerosis and aneurysm formation in ApoE-/- mice.
PMID 19129734·J Cardiovasc Pharmacol·2009
7-preclinical
The synergistic inhibition of atherogenesis in apoE-/- mice between pravastatin and the sPLA2 inhibitor varespladib (A-002).
PMID 19029066·J Lipid Res·2009
7-preclinical
A-002 (Varespladib), a phospholipase A2 inhibitor, reduces atherosclerosis in guinea pigs.
PMID 19222850·BMC Cardiovasc Disord·2009
7-preclinical
Neutrophil chemotaxis by pathogen-associated molecular patterns--formylated peptides are crucial but not the sole neutrophil attractants produced by Staphylococcus aureus.
PMID 16441432·Cell Microbiol·2006
7-preclinical
BanTeC: a software tool for management of corneal transplantation.
PMID 16386632·Transplant Proc·2005
8-other
In vitro antistaphylococcal activity of dalbavancin, a novel glycopeptide.
PMID 15750033·J Antimicrob Chemother·2005
8-other
Conformationally restricted analogs of deoxynegamycin.
PMID 15149653·Bioorg Med Chem Lett·2004
7-preclinical
Peptide deformylase inhibitors as antibacterial agents: identification of VRC3375, a proline-3-alkylsuccinyl hydroxamate derivative, by using an integrated combinatorial and medicinal chemistry approach.
PMID 14693547·Antimicrob Agents Chemother·2004
7-preclinical
Identification of potent and broad-spectrum antibiotics from SAR studies of a synthetic vancomycin analogue.
PMID 12729641·Bioorg Med Chem Lett·2003
8-other
D-Ala-D-lac binding is not required for the high activity of vancomycin dimers against vancomycin resistant enterococci.
PMID 12862465·J Am Chem Soc·2003
8-other
Combinatorial modification of natural products: synthesis and in vitro analysis of derivatives of thiazole peptide antibiotic GE2270 A: A-ring modifications.
PMID 14505638·Bioorg Med Chem Lett·2003
8-other
New antibacterial tetrahydro-4(2H)-thiopyran and thiomorpholine S-oxide and S,S-dioxide phenyloxazolidinones.
PMID 14623003·Bioorg Med Chem Lett·2003
4-observational
Novel oxazolidinone-quinolone hybrid antimicrobials.
PMID 14623004·Bioorg Med Chem Lett·2003
4-observational
Alpha-substituted hydroxamic acids as novel bacterial deformylase inhibitor-based antibacterial agents.
PMID 14623006·Bioorg Med Chem Lett·2003
7-preclinical
N-alkyl urea hydroxamic acids as a new class of peptide deformylase inhibitors with antibacterial activity.
PMID 12183225·Antimicrob Agents Chemother·2002
7-preclinical
A fluorescence-based homogeneous assay for measuring activity of UDP-3-O-(R-3-hydroxymyristoyl)-N-acetylglucosamine deacetylase.
PMID 11237337·Anal Biochem·2001
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 100 WOODS RD.
VALHALLA, NY 10595 - Phone
- (914) 493-7488
Quick Facts
- NPI
- 1669958484
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 11
- Publications
- 20
Are you this provider?
Claim Your Profile